To include your compound in the COVID-19 Resource Center, submit it here.

Abgenix raises $225 million in note deal

Antibody company ABGX raised $225 million in a private placement of convertible

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE